TARS

TARS · Tarsus Pharmaceuticals Inc. Common Stock

View on chart

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

Tarsus Reports XDEMVY Revenue and Option‑Style Retina Deals. The article notes that Tarsus’s drug XDEMVY is now generating revenue to cover operating costs. It also explains that the company’s retina product deals are structured like options, potentially providing flexible upside. These developments may improve the company’s cash flow outlook and support future growth initiatives.

this person other insiders at TARS

Insiders & Stakes

Vivo Capital IX, LLC
10% Owner
2,469,001
Shares held
Ackermann Michael
Director
1,208,273
Shares held
Bobak R. Azamian
President/CEO and Board Chair
837,991
Shares held
William J. Link, PhD
Director
106,786
Shares held
Seshadri Neervannan
Chief Operating Officer
82,791
Shares held
Bryan Wahl
General Counsel
63,959
Shares held
Aziz Mottiwala
Chief Commercial Officer
61,480
Shares held
Jeffrey S. Farrow
See Remarks
56,801
Shares held
Dianne C. Whitfield
Chief Human Resources Officer
35,028
Shares held
Greenstein Leonard M.
CFO, Treasurer
26,785
Shares held
Andrew D. Goldberg
Director
19,654
Shares held
Wendy L. Yarno
Director
16,654
Shares held
Bhaskar Chaudhuri
Director
11,654
Shares held
Scott W. Morrison
Director
7,638
Shares held
Rosemary A. Crane
Director
5,350
Shares held
Elizabeth Yeu Lin
Director
4,770
Shares held
Holdbrook Mark J.
V.P., Clinical Affairs
3,191
Shares held
Trevejo Jose M.
Chief Medical Officer
2,251
Shares held
Katherine Goodrich
Director
2,233
Shares held
David E. I. Pyott
Director
1,383
Shares held

Transaction History

Bobak R. Azamian▼ Sell$801K
Elizabeth Yeu Lin▼ Sell$431K
Elizabeth Yeu Lin▼ Sell$127K
Elizabeth Yeu Lin▼ Sell$340K
Bobak R. Azamian▼ Sell$335K
Bobak R. Azamian▼ Sell$281K
Jeffrey S. Farrow▼ Sell$877K
Katherine Goodrich▼ Sell$183K
William J. Link, PhD▼ Sell$121K
Jeffrey S. Farrow▲ Buy—
William J. Link, PhD▼ Sell$655K
William J. Link, PhD▲ Buy—
Scott W. Morrison▲ Buy—
Bhaskar Chaudhuri▲ Buy—
Katherine Goodrich▲ Buy—
Wendy L. Yarno▲ Buy—
Andrew D. Goldberg▲ Buy—
David E. I. Pyott▲ Buy—
Seshadri Neervannan▼ Sell$200K
Aziz Mottiwala▼ Sell$297K
Elizabeth Yeu Lin▼ Sell$26K
Jeffrey S. Farrow▼ Sell$146K
Bobak R. Azamian▼ Sell$802K
Dianne C. Whitfield▼ Sell$280K
Bryan Wahl▼ Sell$283K
Seshadri Neervannan▼ Sell$307K
Seshadri Neervannan▼ Sell$248K
Aziz Mottiwala▼ Sell$298K
Elizabeth Yeu Lin▼ Sell$26K
Jeffrey S. Farrow▼ Sell$147K
Bobak R. Azamian▼ Sell$802K
Dianne C. Whitfield▼ Sell$280K
Bryan Wahl▼ Sell$283K
Dianne C. Whitfield▼ Sell$280K
Elizabeth Yeu Lin▼ Sell$26K
Bobak R. Azamian▼ Sell$762K
Bryan Wahl▼ Sell$284K
Seshadri Neervannan▼ Sell$217K
Aziz Mottiwala▼ Sell$298K
Jeffrey S. Farrow▼ Sell$147K
William J. Link, PhD▼ Sell$247K
William J. Link, PhD▼ Sell$578K
William J. Link, PhD▼ Sell$34K
Dianne C. Whitfield▲ Buy—
Bryan Wahl▲ Buy—
Seshadri Neervannan▲ Buy—
Aziz Mottiwala▲ Buy—
Jeffrey S. Farrow▲ Buy—
Bobak R. Azamian▲ Buy—
Elizabeth Yeu Lin▲ Buy—
Seshadri Neervannan▼ Sell$641K
Dianne C. Whitfield▼ Sell$74K
Dianne C. Whitfield▼ Sell$68K
Dianne C. Whitfield▼ Sell$458K
Dianne C. Whitfield▼ Sell$656K
Bobak R. Azamian▼ Sell$449K
Bobak R. Azamian▼ Sell$47K
Seshadri Neervannan▼ Sell$0
Seshadri Neervannan▼ Sell$0
Dianne C. Whitfield▼ Sell$592K
Elizabeth Yeu Lin▼ Sell$165K
Katherine Goodrich▲ Buy—
William J. Link, PhD▼ Sell$408K
William J. Link, PhD▼ Sell$516K
William J. Link, PhD▼ Sell$95K
William J. Link, PhD▼ Sell$458K
William J. Link, PhD▼ Sell$388K
Elizabeth Yeu Lin▲ Buy—
Bobak R. Azamian▼ Sell$0
Bobak R. Azamian▼ Sell$332K
William J. Link, PhD▼ Sell$0
Scott W. Morrison▲ Buy—
William J. Link, PhD▼ Sell$1.5M
Bobak R. Azamian▼ Sell$300K
Jeffrey S. Farrow▼ Sell$550K
Jeffrey S. Farrow▲ Buy—
Elizabeth Yeu Lin▼ Sell$41K
Elizabeth Yeu Lin▲ Buy—
Bhaskar Chaudhuri▲ Buy—
Andrew D. Goldberg▲ Buy—
Wendy L. Yarno▲ Buy—
Scott W. Morrison▲ Buy—
William J. Link, PhD▲ Buy—
Aziz Mottiwala▼ Sell$766K
Bobak R. Azamian▼ Sell$300K
Dianne C. Whitfield▼ Sell$107K
Bobak R. Azamian▼ Sell$428K
Jeffrey S. Farrow▼ Sell$59K
Aziz Mottiwala▼ Sell$169K
Seshadri Neervannan▼ Sell$122K
Bryan Wahl▼ Sell$155K
Dianne C. Whitfield▼ Sell$107K
Bobak R. Azamian▼ Sell$405K
Jeffrey S. Farrow▼ Sell$59K
Aziz Mottiwala▼ Sell$169K
Seshadri Neervannan▼ Sell$121K
Bryan Wahl▼ Sell$155K
Dianne C. Whitfield▼ Sell$107K
Bobak R. Azamian▼ Sell$330K
Jeffrey S. Farrow▼ Sell$59K
Aziz Mottiwala▼ Sell$169K
Seshadri Neervannan▼ Sell$121K
Bryan Wahl▼ Sell$155K
Bryan Wahl▲ Buy—
Seshadri Neervannan▲ Buy—
Aziz Mottiwala▲ Buy—
Jeffrey S. Farrow▲ Buy—
Bobak R. Azamian▲ Buy—
Dianne C. Whitfield▲ Buy—
Andrew D. Goldberg▲ Buy$90K
Scott W. Morrison▼ Sell$0
Scott W. Morrison▲ Buy—
William J. Link, PhD▼ Sell$133K
William J. Link, PhD▼ Sell$780K
William J. Link, PhD▼ Sell$0
William J. Link, PhD▼ Sell$0
William J. Link, PhD▼ Sell$0
Elizabeth Yeu Lin▲ Buy—
Scott W. Morrison▲ Buy—
Bhaskar Chaudhuri▲ Buy—
William J. Link, PhD▲ Buy—
Rosemary A. Crane▲ Buy—
Andrew D. Goldberg▲ Buy—
Wendy L. Yarno▲ Buy—
Jeffrey S. Farrow▼ Sell$287K
Jeffrey S. Farrow▲ Buy—
Aziz Mottiwala▼ Sell$146K
Bobak R. Azamian▼ Sell$319K
Bryan Wahl▼ Sell$136K
Dianne C. Whitfield▼ Sell$132K
Seshadri Neervannan▼ Sell$149K
Aziz Mottiwala▲ Buy—
Bobak R. Azamian▲ Buy—
Dianne C. Whitfield▲ Buy—
Bryan Wahl▲ Buy—
Seshadri Neervannan▲ Buy—
Bobak R. Azamian▼ Sell$162K
Trevejo Jose M.▼ Sell$45K
Bobak R. Azamian▼ Sell$188K
Bobak R. Azamian▼ Sell$622K
Andrew D. Goldberg▲ Buy$19K
Wendy L. Yarno▲ Buy—
Dianne C. Whitfield▼ Sell$136K
Bryan Wahl▼ Sell$136K
Dianne C. Whitfield▲ Buy$0
Bryan Wahl▲ Buy$0
Bobak R. Azamian▼ Sell$52K
Bobak R. Azamian▼ Sell$91K
Bobak R. Azamian▼ Sell$4K
Bobak R. Azamian▼ Sell$106K
Trevejo Jose M.▼ Sell$29K
Bobak R. Azamian▼ Sell$138K
Scott W. Morrison▲ Buy—
Bobak R. Azamian▼ Sell$138K
Elizabeth Yeu Lin▲ Buy$160K
Aziz Mottiwala▼ Sell$48K
Bobak R. Azamian▼ Sell$80K
Bobak R. Azamian▼ Sell$2.0M
Bobak R. Azamian▼ Sell$156K
Bobak R. Azamian▼ Sell$149K
Bhaskar Chaudhuri▲ Buy—
Wendy L. Yarno▲ Buy—
Andrew D. Goldberg▲ Buy—
Elizabeth Yeu Lin▲ Buy—
William J. Link, PhD▲ Buy—
Rosemary A. Crane▲ Buy—
Bobak R. Azamian▼ Sell$167K
Bobak R. Azamian▼ Sell$62K
Aziz Mottiwala▼ Sell$2K
Aziz Mottiwala▼ Sell$48K
Aziz Mottiwala▼ Sell$40K
Bobak R. Azamian▼ Sell$127K
William J. Link, PhD▼ Sell$0
William J. Link, PhD▼ Sell$0
Bobak R. Azamian▼ Sell$151K
Bobak R. Azamian▼ Sell$88K
Bobak R. Azamian▼ Sell$65K
Bobak R. Azamian▼ Sell$35K
Greenstein Leonard M.▼ Sell$70K
Bobak R. Azamian▼ Sell$109K
Aziz Mottiwala▼ Sell$5K
Seshadri Neervannan▼ Sell$5K
Bryan Wahl▼ Sell$5K
Bobak R. Azamian▼ Sell$9K
Dianne C. Whitfield▼ Sell$4K
Greenstein Leonard M.▼ Sell$4K
Trevejo Jose M.▼ Sell$6K
Seshadri Neervannan▼ Sell$5K
Bryan Wahl▼ Sell$5K
Bobak R. Azamian▼ Sell$9K
Dianne C. Whitfield▼ Sell$4K
Aziz Mottiwala▼ Sell$5K
Greenstein Leonard M.▼ Sell$4K
Trevejo Jose M.▼ Sell$7K
Seshadri Neervannan▼ Sell$5K
Bryan Wahl▼ Sell$5K
Bobak R. Azamian▼ Sell$9K
Dianne C. Whitfield▼ Sell$4K
Aziz Mottiwala▼ Sell$4K
Greenstein Leonard M.▼ Sell$4K

We use analytics to understand how market-wall is used. No personal data is sold.